Clinical Trial: Middle Meningeal Artery Embolisation in Chronic Subdural Hematoma

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07751887) titled 'Middle Meningeal Artery Embolisation in Chronic Subdural Hematoma' on Aug. 03.

Brief Summary: This international multicenter study evaluates the efficacy and safety of middle meningeal artery embolization (MMAE) using PVA particles or liquid embolic agents as a perioperative treatment to prevent the recurrence of chronic subdural hematoma (cSDH). All participating patients across centers in the Czech Republic and Slovakia will receive the minimally invasive MMAE procedure within 7 days prior to or after surgical evacuation, with the primary goal of assessing hematoma recurrence rates and procedure-related complications over a 90-day ...